metformin has been researched along with insulin glulisine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Bergenstal, RM; Hollander, P; Johnson, M; Powers, MA; Rendell, M; Vlajnic, A; Wynne, A | 1 |
Bailey, TS; Bode, BW; Brunelle, R; Chen, X; Edelman, SV; Frias, JP; Kipnes, MS | 1 |
Cersosimo, E; Cervera, A; DeFronzo, RA; Fernandez, M; Ghosh, S; Joya-Galeana, J; Musi, N; Reyna, S; Triplitt, C | 1 |
Del Prato, S; Leotta, S; Lovagnini-Scher, AC; Nicolucci, A; Turco, S; Vespasiani, G | 1 |
Cui, N; Guo, L; Jiang, X; Liu, J; Mu, Y; Wang, G; Xu, B; Zhang, X | 1 |
5 trial(s) available for metformin and insulin glulisine
Article | Year |
---|---|
Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine.
Topics: Adult; Aged; Algorithms; Blood Glucose; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Dose-Response Relationship, Drug; Drug Administration Schedule; Eating; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Male; Metformin; Middle Aged; Racial Groups; United States | 2008 |
Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimen.
Topics: Adult; Aged; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Infusion Systems; Intention to Treat Analysis; Male; Metformin; Middle Aged; Patient Selection; Pilot Projects; Treatment Outcome | 2010 |
Effects of insulin and oral anti-diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects.
Topics: Adult; Body Mass Index; Carotid Arteries; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Glargine; Insulin Resistance; Insulin, Long-Acting; Male; Metformin; Mexican Americans; Middle Aged; Muscle, Skeletal; Myositis; Pioglitazone; Sulfonylurea Compounds; Thiazolidinediones; Tunica Intima | 2011 |
Telecare Provides comparable efficacy to conventional self-monitored blood glucose in patients with type 2 diabetes titrating one injection of insulin glulisine-the ELEONOR study.
Topics: Adult; Aged; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; Fasting; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Injections; Insulin; Male; Metformin; Middle Aged; Monitoring, Physiologic; Postprandial Period; Telemedicine; Treatment Outcome | 2012 |
Efficacy and Safety of Basal Insulin-Based Treatment Versus Twice-Daily Premixed Insulin After Short-Term Intensive Insulin Therapy in Patients with Type 2 Diabetes Mellitus in China: Study Protocol for a Randomized Controlled Trial (BEYOND V).
Topics: Adolescent; Adult; Aged; Blood Glucose; China; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin, Long-Acting; Male; Metformin; Middle Aged; Multicenter Studies as Topic; Patient Satisfaction; Randomized Controlled Trials as Topic; Young Adult | 2020 |
2 other study(ies) available for metformin and insulin glulisine
Article | Year |
---|---|
[Intensified insulin therapy. Is there an alternative to BE count?].
Topics: Algorithms; Blood Glucose Self-Monitoring; Diabetes Mellitus; Diet, Diabetic; Dose-Response Relationship, Drug; Drug Administration Schedule; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Metformin; Postprandial Period; Randomized Controlled Trials as Topic | 2006 |
[Researchers illuminate diabetes therapy].
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Disease Progression; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Metformin | 2014 |